consideration during the process of researching and 
developing such countermeasures and products.’’. 
(b) STRATEGIC INITIATIVES.—Clause (ii) of section 
319L(c)(4)(F) of the Public Health Service Act (42 
U.S.C. 247d–7e(c)(4)(F)) is amended to read as follows: 
‘‘(ii) threats that consistently exist or 
continually circulate and have a significant 
potential to become a pandemic, such as 
pandemic influenza and emerging infec-
tious diseases in combination with under-
lying non-communicable diseases, which 
may include the advanced research and de-
velopment, manufacturing, and appropriate 
stockpiling of qualified pandemic or epi-
demic products, and products, technologies, 
or processes to support the advanced re-
search and development of such counter-
measures (including multiuse platform 
technologies for diagnostics, vaccines, and 
therapeutics; virus seeds; clinical trial lots; 
novel virus strains; and antigen and adju-
vant material); and’’. 
(c) AT-RISK INDIVIDUALS.—Paragraph (6) of section 
319L(c) of the Public Health Service Act (42 U.S.C. 
247d–7e(c)) is amended to read as follows: 
VerDate Sep 11 2014 
19:02 Jul 28, 2020
Jkt 099200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H7527.IH
H7527
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(6) AT-RISK
INDIVIDUALS.—In carrying out 
the functions under this section, the Secretary may 
give a priority to advanced research and develop-
ment of— 
‘‘(A) qualified countermeasures and quali-
fied pandemic or epidemic products likely to be 
safe and effective with respect to vulnerable 
American populations; and 
‘‘(B) population health products likely to 
protect vulnerable American populations with 
underlying non-communicable diseases from dis-
proportionate 
harm 
in 
epidemics 
and 
pandemics.’’. 
(d) OTHER AUTHORITIES.—Section 319L(c) of the 
Public Health Service Act (42 U.S.C. 247d–7e(c)) is 
amended by adding at the end the following: 
‘‘(8) 
TIMELY
DELIVERY
OF
POPULATION 
HEALTH PRODUCTS TO AT-RISK INDIVIDUALS.—The 
Secretary shall collaborate with the Administrator of 
the Centers for Medicare & Medicaid Services, the 
Secretary of Defense, the Secretary of Veterans Af-
fairs, the Commissioner of Food and Drugs, and the 
heads of other Federal agencies involved with ap-
proval and distribution of health products to assure 
that such Federal agencies distribute approved pop-
VerDate Sep 11 2014 
19:02 Jul 28, 2020
Jkt 099200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H7527.IH
H7527
pamtmann on DSKBC07HB2PROD with BILLS
ulation health products as promptly and effectively 
as possible, and as continuously as possible, to pro-
tect vulnerable American populations from harm in 
epidemics and pandemics. 
‘‘(9) REPORT ON NEED FOR INCENTIVIZING DE-
VELOPMENT OF POPULATION HEALTH PRODUCTS.— 
Not later than 90 days after the date of enactment 
of the Medical Manufacturing, Economic Develop-
ment, and Sustainability Act of 2020, the Secretary 
shall examine and report to the Congress on— 
‘‘(A) the extent to which the health of 
aging Americans, African Americans, His-
panics, Native Americans, veterans, or other 
vulnerable American populations has been dis-
proportionately harmed by the COVID–19 pan-
demic and prior epidemics and pandemics; 
‘‘(B) the population health products cur-
rently available and whether there is a need for 
additional 
innovation 
and 
development 
to 
produce population health products to reduce 
the exposure of vulnerable American popu-
lations to risk of disproportionate harm in 
epidemics and pandemics; and 
‘‘(C) whether the Secretary recommends 
providing the same incentives for the develop-
VerDate Sep 11 2014 
19:02 Jul 28, 2020
Jkt 099200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H7527.IH
H7527
pamtmann on DSKBC07HB2PROD with BILLS
ment and marketing of population health prod-
ucts as is given with respect to covered infec-
tious disease products under the Federal Food, 
Drug, and Cosmetic Act, including under sec-
tion 505E of such Act.’’. 
Æ 
VerDate Sep 11 2014 
19:02 Jul 28, 2020
Jkt 099200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6301
E:\BILLS\H7527.IH
H7527
pamtmann on DSKBC07HB2PROD with BILLS